Section 1 Short title
This Act may be cited as the “Pass-Through Technical Corrections Act”.
Pass-Through Technical Corrections Act
A BILL
To clarify the treatment of pass-through status under the Medicare outpatient payment system for certain drugs.
Sec. 2 Clarification of pass-through status under Medicare OPPS for certain drugs
Notwithstanding section 1301 of the Consolidated Appropriations Act of 2018 (Public Law 115–141), in the case of a radiopharmaceutical drug for which pass-through status was provided pursuant to section 1833(t)(6) of the Social Security Act (42 U.S.C. 1395l(t)(6)) and whose period of pass-through status initially expired on either December 31, 2017, or December 31, 2018, if such radiopharmaceutical drug is indicated for positron emission tomography beta amyloid imaging covered under a coverage evidence development determination under section 1862(a)(1)(E) of the Social Security Act (42 U.S.C. 1395y(a)(1)(E)), then such pass-through status shall be extended until such date that the coverage with evidence development review is determined by the Centers for Medicare & Medicaid Services to be completed.